Filing Flows › Niagen Bioscience (NAGE) › Operating margin
Niagen Bioscience (NAGE) operating margin by quarter
Niagen Bioscience's operating margin was 2.4% in Q2 2026 (second quarter 2026), -2.7 pts from Q1 2026. Over the last 6 quarters it ranged from 2.4% (Q2 2026) to 15.7% (Q1 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | 2.4% | -2.7 pts | -7.9 pts |
| Q1 2026 | 5.0% | -7.1 pts | -10.6 pts |
| Q4 2025 | 12.1% | -0.4 pts | — |
| Q3 2025 | 12.5% | +2.2 pts | — |
| Q2 2025 | 10.2% | -5.4 pts | — |
| Q1 2025 | 15.7% | — | — |
Q2 2026 at a glance
Niagen Bioscience, Q2 2026: revenue $29.8M (-4% year over year), operating margin 2.4%, net earnings $963K, operating cash flow $2.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Niagen Bioscience's operating margin?
Niagen Bioscience's operating margin was 2.4% in Q2 2026 (second quarter 2026), -2.7 pts from Q1 2026.
How has Niagen Bioscience's operating margin changed?
Over the last 6 quarters it ranged from 2.4% (Q2 2026) to 15.7% (Q1 2025).